| 1 |
33553369 | Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report. | 2021 Jan |
1 |
| 2 |
34664206 | Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions. | 2021 Oct |
2 |
| 3 |
33123800 | Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3. | 2020 Oct 29 |
3 |
| 4 |
29944058 | Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis. | 2019 Oct |
1 |
| 5 |
30652318 | Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes. | 2019 Feb |
2 |
| 6 |
29719454 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans. | 2018 May |
1 |
| 7 |
27174018 | Impact of curcumin on the pharmacokinetics of rosuvastatin in rats and dogs based on the conjugated metabolites. | 2017 Mar |
1 |
| 8 |
27737931 | Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin. | 2017 Jan |
1 |
| 9 |
25261337 | Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. | 2014 Dec 18 |
1 |
| 10 |
21717139 | The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. | 2011 Dec |
2 |
| 11 |
18617601 | Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. | 2008 Oct |
2 |